KRN 8602

Known as: KRN-8602 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-1995
0119881995

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
Positively charged doxorubicin (DOX) and non-positively charged anthracyclines, aclarubicin (ACR) and morpholino-carminomycin… (More)
Is this relevant?
Review
1994
Review
1994
We summarize here the antitumor activity of newly developed drugs against malignant lymphoma. Irinotecan hydrochloride (CPT-11… (More)
Is this relevant?
1994
1994
The effects of heat on intracellular accumulation of anthracyclines were investigated by laser flow cytometry analysis. Sarcoma… (More)
  • figure 2
  • figure 3
  • figure 4
  • figure 5
  • table 1
Is this relevant?
Review
1993
Review
1993
Idarubicin showed the superior activity against Acute Non-Lymphocytic Leukemia (ANLL) in the prospective randomized trials… (More)
Is this relevant?
1991
1991
The pharmacokinetic properties of KRN 8602, an anthracycline compound, was studied by HPLC following intravenous administration… (More)
Is this relevant?
1990
1990
  • Hj Majima
  • Gan to kagaku ryoho. Cancer & chemotherapy
  • 1990
KRN 8602 is a new antineoplastic drug with the chemical structure, 3'-deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin… (More)
Is this relevant?
Review
1988
Review
1988
Effort looking for new antitumor antibiotics useful for the treatment of curing cancer resulted to the discovery of a number of… (More)
Is this relevant?